Clinical Trial Update: The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis [Phase 3]

View source ↗

Summary

This Phase 3 trial compares Anidulafungin with a comparator in patients with candidemia or invasive candidiasis to evaluate safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Invasive Candidiasis

Drugs mentioned

• Anidulafungin (anidulafungin)

Snippet

Sponsor: Pfizer | Conditions: Candidiasis | Phase 3 | Status: COMPLETED